Subscribe To
Allogene therapeutics announces oral presentation of phase 1 data on allo-501/501a in large b cell lymphoma at the international conference on malignant lymphoma (icml) lugano
Long-Term Follow Up Data from Phase 1 ALPHA/ALPHA2 Trials demonstrates Potential of Allogeneic CD19 CAR...
June 9, 2023, 10:25 pm
Report: meta demonstrates text-based app to employees while preparing launch
Meta has reportedly demonstrated its upcoming text-based app to employees. The app was shown during an all-hands meeting Thursday (June 8) and was ...
June 9, 2023, 5:30 pm
Successful primary engraftment of trem-cel in first five aml patients demonstrates promise of vor bio’s platform
Patients transplanted with trem-cel achieved primary neutrophil engraftment and high levels of myeloid donor chimerism. Strong investigator enthusiasm...
June 9, 2023, 11:30 am
Technical outlook and review
DXY: The DXY (US Dollar Index) chart demonstrates a bearish momentum, supported by the fact that the pr...
June 9, 2023, 7:30 am
Report shows powerful results from career-connected math
Curriculum demonstrates positive results for student engagement, math performance, and future education...
June 7, 2023, 3:00 pm
Buy 3 june dogs of the dow, watch 4
"The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is...
June 6, 2023, 6:44 pm
Transition metals pinpoints large gold exploration target at jolly gold
Transition Metals Corp (TSX-V:XTM) has provided a salient interpretation of results from fieldwork completed at the company's wholly owned and optione...
June 6, 2023, 11:00 am
Valero energy: keeping a keen eye on diversification reveals solid potential
Valero Energy demonstrates strong fundamentals and commitment to growth through investment and diversif...
June 5, 2023, 10:20 am
Trump’s persistent election result denials demonstrate the need for bitcoin-verified truth
Donald Trump’s tireless 2020 election denials, and the fact that voters don’t know what to believe, demons...
June 3, 2023, 12:14 pm
Nuscale power ($smr) demonstrates emission reducing capabilities of small modular reactors
New research from NuScale Power (NYSE: SMR) has demonstrated the advanced capabilities of NuScale small modular reactors (SMRs) for reducing emissions...
May 31, 2023, 2:06 pm
Why coca-cola, costco, and starbucks are no-brainer buys right now
Coca-Cola is as reliable as you can get for dividend payments. Costco still draws new members and demonstrates...
May 31, 2023, 5:10 am
Mastercard: i was too cautious (rating upgrade)
Mastercard's recent financial performance and double-digit revenue growth in a challenging environment indicate a bullish outlook. MA is well-position...
May 30, 2023, 11:17 pm
Centerspace: rental growth will fuel growth in 2023 and beyond
Centerspace demonstrates strong Q1 2023 performance with a focus on key areas like Minneapolis and Denv...
May 30, 2023, 6:07 am
Decoding sentinelone's ai edge: the next big leap in cybersecurity
SentinelOne, a cybersecurity firm, demonstrates strong growth with a 92% YoY revenue increase in Q4 202...
May 30, 2023, 3:39 am
3 top growth stocks to make you the millionaire next door
The Millionaire Next Door is a timeless book that explores the habits ordinary people use to become millionaires. The book ...
May 29, 2023, 2:47 pm
Macrogenics: non-dilutive funding propels drug candidates (rating upgrade)
MacroGenics demonstrates promise with its drug lorigerlimab for mCRPC treatment, despite a recent 18% s...
May 29, 2023, 2:47 am
Global business intelligence market is set to reach us$ 56.2 billion by the forecast period 2033 end at a cagr of 7.1% | data analysis by future market insights, inc.
The United States is witnessing robust growth in the business intelligence market, with a projected CAGR of 7.0% from 2023 to 2033. By the end of 2033...
May 26, 2023, 11:30 am
Greenland technologies holding corp ceo raymond wang buys 66,500 shares
On May 22, 2023, Raymond Wang, CEO of Greenland Technologies Holding Corp ( GTEC , Financial), purchased 66,500 shares of the company's stock. This mo...
May 25, 2023, 10:26 pm
Updated linvoseltamab (bcmaxcd3) data from pivotal trial demonstrates early, deep and durable responses in patients with heavily pre-treated multiple myeloma
71% objective response rate, with 59% of patients achieving a very good partial response or better at the recommended 200 mg dose, per new data to be ...
May 25, 2023, 9:05 pm
Insider buying: ceo pablo legorreta acquires 150,000 shares of royalty pharma plc (rprx)
On May 24, 2023, Pablo Legorreta, CEO, Chairman of the Board, and 10% Owner of Royalty Pharma PLC ( RPRX , Financial), purchased 150,000 shares of the...
May 25, 2023, 6:06 pm